Gagnon Advisors, LLC Pacira Bio Sciences, Inc. Transaction History
Gagnon Advisors, LLC
- $137 Million
- Q2 2025
A detailed history of Gagnon Advisors, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Gagnon Advisors, LLC holds 213,402 shares of PCRX stock, worth $4.61 Million. This represents 3.72% of its overall portfolio holdings.
Number of Shares
213,402
Previous 133,390
59.98%
Holding current value
$4.61 Million
Previous $3.31 Million
53.89%
% of portfolio
3.72%
Previous 2.66%
Shares
11 transactions
Others Institutions Holding PCRX
# of Institutions
256Shares Held
51MCall Options Held
157KPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$173 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.24MShares$113 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$48.9 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.24MShares$48.4 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.05MShares$44.3 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $990M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...